` 298380 (ABL Bio Inc) vs KOSPI 200 Comparison - Alpha Spread

298380
vs
KOSPI 200

Over the past 12 months, has significantly outperformed KOSPI 200, delivering a return of 35% compared to the KOSPI 200's 6% drop.

Stocks Performance
298380 vs KOSPI 200

Loading

Performance Gap
298380 vs KOSPI 200

Loading
298380
KOSPI 200
Difference

Performance By Year
298380 vs KOSPI 200

Loading
298380
KOSPI 200
Add Stock

Competitors Performance
ABL Bio Inc vs Peers

KOSPI 200
298380
ABBV
AMGN
GILD
VRTX
Add Stock

ABL Bio Inc
Glance View

Market Cap
1.6T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
9 717.33 KRW
Overvaluation 71%
Intrinsic Value
Price
A
Back to Top